Create and deliver bespoke Real-World Insights (RWI) projects with drug development software and bioinformatics services tailored to your unique requirements
Customize in-house access of data for analyses with public and internal datasets and drug development software for immediate insights to inform your translational and clinical development teams.
Our specialized team works with you to develop the informatics tools and evidence resources you need to get consistent, reliable, and actionable results through all phases of your study.
With QIAGEN Real-World Insights, you can use real-world genomic data to:
The QIAGEN Real-World Insights (RWI) portfolio combines robust real-world genomic data from over 200,000 cancer cases and drug development software to optimize clinical trial designs and market strategies.
To access RWI, you can:
Do you have novel questions, hypotheses, and hurdles to overcome? Our team of scientists, bioinformaticists, and clinicians can help you strategize, customize, and deliver within your timeline.
Choose the best biomarkers and cancer indications for your molecularly targeted therapies
Identify appropriate patient cohorts and enhance your CDx design to improve stratification and success
Expand beyond the one biomarker, one drug paradigm with expert molecular profiling and drug-response analyses